This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Elevance Health Securities Class Action
Business securities lawsuit

Elevance Health Securities Class Action

Analysis based on 10 articles · First reported May 16, 2025 · Last updated Jun 06, 2025

Sentiment
-70
Attention
4
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is impacted by the significant decline in Elevance Health's stock price due to alleged misleading statements and increased Medicaid costs. This event highlights the risks associated with healthcare companies' financial reporting and government program dependencies, potentially leading to increased scrutiny of similar firms.

Healthcare Legal Services
Event Summary

Elevance Health is facing a federal securities class action lawsuit led by Faruqi & Faruqi. The lawsuit alleges that Elevance Health and its executives made false and misleading statements to investors between April 18, 2024, and October 16, 2024, regarding its Medicaid cost trends and the sufficiency of premium rates. The truth began to emerge on July 17, 2024, when Elevance Health disclosed an expected increase in second-half Medicaid utilization, causing its stock to drop by 5.8%. Further revelations on October 17, 2024, showed Elevance Health missed Q3 2024 EPS expectations by 13.7% and lowered its full-year EPS guidance by 11.3% due to elevated Medicaid medical costs, resulting in another 10.6% stock price decline. Investors who suffered losses are encouraged by James Wilson of Faruqi & Faruqi to join the class action, with a lead plaintiff deadline of July 11, 2025.

Key Actions
100 Elevance Health missed EPS expectations
95 Elevance Health made misleading statements
90 Elevance Health stated
90 Faruqi & Faruqi filed class action Elevance Health
Entities Involved
stock
Elevance Health
Elevance Health is facing a federal securities class action lawsuit for allegedly making false and misleading statements regarding its Medicaid costs and guidance, leading to significant stock price declines.
Importance 100.0 Sentiment -75.0
priv
Faruqi & Faruqi
Faruqi & Faruqi, a national securities law firm, is investigating and leading the class action lawsuit against Elevance Health on behalf of investors.
Importance 80.0 Sentiment 20.0
per
James Wilson
James Wilson, a partner at Faruqi & Faruqi, is encouraging investors who suffered losses in Elevance Health to contact him regarding their legal options.
Importance 60.0 Sentiment 10.0
Relationships
Faruqi & Faruqi related ↔ James Wilson
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.